Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Hydroxyzine pamoate
Cat. No.:
OB0225LY-0172
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Product Overview
Description:
Hydroxyzine pamoate is an antihistamine with anxiolytic and sedative properties.
Synonym:
Hydroxyzine embonate; Bobsule; Equipose; 10246-75-0; Hydroxyzine (pamoate); Hydroxyzine pamoate salt; Hy-Pam; 2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)ethan-1-ol 4,4'-methylenebis(3-hydroxy-2-naphthoate)
CAS No.:
10246-75-0
Compound CID:
25096
Formula:
C44H43ClN2O8
Formula Weight:
763.27
Specification
Relative Density:
1.182 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Hydroxyzine pamoate can be used to study the mechanisms of anxiety-related disorders.
Library Information
Targets:
Histamine receptor family
Receptors:
H1 receptor
Pathways:
GPCR/G protein; Neuronal signaling; Immunology/Inflammation
Plate Number:
AOCL-3
Plate Location:
b5
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
27.5 mg/mL; 36.03 mM
